BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that its Chief Scientific Advisor and Co-Founder, Eric N. Olson, Ph.D., will give a plenary lecture at the joint meeting of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP). The lecture, which is scheduled to take place at 10:15 a.m. on Saturday, April 24, 2010, at The Fairmont Chicago, will highlight recent miRNA discoveries in a variety of areas being pursued by the company.
